Kozawa Eiji, Nishida Yoshihiro, Nakashima Hiroatsu, Tsukushi Satoshi, Toriyama Kazuhiro, Kamei Yuzuru, Ishiguro Naoki
Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550.
Oncol Lett. 2012 Jan;3(1):82-88. doi: 10.3892/ol.2011.427. Epub 2011 Sep 22.
Oncological and functional prognostic factors for patients with foot sarcomas have yet to be clarified. This study was undertaken to identify the prognostic factors for oncological and functional outcomes and the significance of adjuvant radiotherapy in achieving local control in patients with foot sarcomas. We reviewed 31 consecutive patients with soft tissue (24), and bone (7) sarcomas arising in the foot and analyzed the impact of patient characteristics on the functional and oncological outcomes. There were seven cases with clear cell or epithelioid sarcomas. Two of the 31 cases experienced local recurrence despite the fact that only two cases received adjuvant radiotherapy. Sixteen out of 18 cases of soft tissue sarcomas with limb salvage surgery underwent reconstructive procedures for soft tissue defects. Amputation required as a surgical treatment (p=0.002) was a poor prognostic factor. Larger size (p=0.029) and bone reconstruction (p=0.018) were poor prognostic factors for local recurrence-free survival, and amputation (p=0.001) and bone reconstruction (p=0.008) for metastasis-free survival in patients with soft tissue sarcomas. No significant factors were derived in patients with bone sarcomas. Larger size (p=0.021), amputation (p=0.016) and bone reconstruction (p=0.03) were poor prognostic factors affecting function in patients with soft tissue sarcomas, and hindfoot site (p=0.028) and amputation (p=0.028) were poor prognostic factors affecting function in patients with bone sarcomas. Surgery with a negative operative margin and reconstructive procedures achieved good local control and function. Patients that had tumors with larger size, necessitating amputation or bone reconstruction, required novel multimodal treatment in order to improve their outcomes.
足部肉瘤患者的肿瘤学和功能预后因素尚未明确。本研究旨在确定肿瘤学和功能结局的预后因素,以及辅助放疗在实现足部肉瘤患者局部控制中的意义。我们回顾了31例连续发生于足部的软组织肉瘤(24例)和骨肉瘤(7例)患者,并分析了患者特征对功能和肿瘤学结局的影响。其中有7例透明细胞或上皮样肉瘤。31例中有2例出现局部复发,尽管只有2例接受了辅助放疗。18例接受保肢手术的软组织肉瘤患者中有16例针对软组织缺损进行了重建手术。作为手术治疗需要截肢(p = 0.002)是一个不良预后因素。较大的肿瘤尺寸(p = 0.029)和骨重建(p = 0.018)是软组织肉瘤患者无局部复发生存的不良预后因素,而截肢(p = 0.001)和骨重建(p = 0.008)是软组织肉瘤患者无转移生存的不良预后因素。骨肉瘤患者未得出显著因素。较大的肿瘤尺寸(p = 0.021)、截肢(p = 0.016)和骨重建(p = 0.03)是影响软组织肉瘤患者功能的不良预后因素,而后足部位(p = 0.028)和截肢(p = 0.028)是影响骨肉瘤患者功能的不良预后因素。手术切缘阴性和重建手术实现了良好的局部控制和功能。肿瘤尺寸较大、需要截肢或骨重建的患者需要新的多模式治疗以改善其结局。